# Human mesenchymal stem cell therapy in severe COVID-19 patients: 2-year follow-up results of a randomized, double-blind, placebo-controlled trial

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/human-mesenchymal-stem-cell-therapy-in-severe-covid-19-patients-2-year-follow-up/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Tiantian Li,Bo Zhang,Hui Fang,Ming Shi,Weiqi Yao,Yuanyuan Li,Chao Zhang,Jin‐Wen Song,Lei Huang,Zhe Xu,Xin Yuan,Junliang Fu,Cheng Zhen,Yu Zhang,Ze-Rui Wang,Ziying Zhang,Mengqi Yuan,Tengyun Dong,Ruidan Bai,Lulu Zhao,Jianming Cai,Jinghui Dong,Jianzeng Zhang,Wei‐Fen Xie,Yonggang Li,Lei Shi,Fu‐Sheng Wang |
| Citations | 34 |
| DOI | 10.1016/j.ebiom.2023.104600 |
| Fields | Medicine |
| Open Access | true |
| OA Status | gold |
| OA URL | http://www.thelancet.com/article/S2352396423001652/pdf |
| OpenAlex ID | https://openalex.org/W4372284459 |
| PMID | 37149930 |
| Type | article |
| Year | 2023 |

## Paper authors

- [Ruidan Bai](https://scholariq.org/researchers/ruidan-bai/)

## Paper journal

- [EBioMedicine](https://scholariq.org/journals/ebiomedicine/)

## Paper primary topic

- [Mesenchymal stem cell research](https://scholariq.org/topics/mesenchymal-stem-cell-research/)

## Paper topics

- [Mesenchymal stem cell research](https://scholariq.org/topics/mesenchymal-stem-cell-research/)
- [COVID-19 Clinical Research Studies](https://scholariq.org/topics/covid-19-clinical-research-studies/)
- [Dermatological and COVID-19 studies](https://scholariq.org/topics/dermatological-and-covid-19-studies/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.